 |
artemether/lumefantrine |
|---|---|
| Trade Name | Coartem |
| Orphan Indication | For the treatment of infections due to Plasmodium falciparum or mixed infections including P. falciparum. |
| USA Market Approval | USA |
| USA Designation Date | 2007-08-31 00:00:00 |
| Sponsor | Novartis Pharmaceuticals;Bldg 405/4051, One Health Plaza;East Hanover, New Jersey, 07936 |
